Once the favorite of the rich and famous, the Q7 has received its second facelift in nearly three years to bring it up to speed with more modern competition.
Anthem Biosciences, a CRDMO, has filed for a Rs 3,395 crore IPO. The offer comprises an OFS by promoters and investors, including True North.
New York Judge Delays Start of Trial Between CFTC and Gemini Trust Company ...